Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 12

Results For "advisory"

165 News Found

Bug Bite Thing partnership with certified pediatrician Dr. Mona Amin
News | July 25, 2022

Bug Bite Thing partnership with certified pediatrician Dr. Mona Amin

Dr. Mona frequently treats children experiencing localized reactions from insect bites and stings.


Strand Life Sciences presents report on ‘Genomic Surveillance of SARS-CoV-2’
News | July 18, 2022

Strand Life Sciences presents report on ‘Genomic Surveillance of SARS-CoV-2’

Strand Life Sciences has sequenced a total of 12800 samples from July, 2021 to June, 2022, and identified more than a 100 lineages circulating in Bengaluru


India’s first homegrown mRNA COVID-19 vaccine likely to have low market penetration, says GlobalData
News | July 11, 2022

India’s first homegrown mRNA COVID-19 vaccine likely to have low market penetration, says GlobalData

Proportion of the eligible population yet to receive a COVID-19 vaccine is comparatively small


Govt introduces 'Draft of New Drugs, Medical Devices and Cosmetics Bill, 2022'
Policy | July 11, 2022

Govt introduces 'Draft of New Drugs, Medical Devices and Cosmetics Bill, 2022'

The Bill aims to amend and consolidate the law relating to the import, manufacture, distribution and sale of drugs, medical devices and cosmetics


Sanofi flu vaccines licensed and approved for 2022-2023 influenza season
Drug Approval | July 05, 2022

Sanofi flu vaccines licensed and approved for 2022-2023 influenza season

Sanofi will begin to ship their vaccines helping to ensure more people will be immunized


Pfizer and BioNTech announce Omicron-adapted COVID-19 vaccine candidates demonstrate high immune response against omicron
News | June 27, 2022

Pfizer and BioNTech announce Omicron-adapted COVID-19 vaccine candidates demonstrate high immune response against omicron

Both vaccine candidates demonstrated a favorable safety and tolerability profile similar to the Pfizer-BioNTech COVID-19 Vaccine


Marinus expands enrollment criteria to support recruitment in Phase 3 RAISE Trial in refractory status epilepticus
Clinical Trials | June 10, 2022

Marinus expands enrollment criteria to support recruitment in Phase 3 RAISE Trial in refractory status epilepticus

Marinus has broadened inclusion criteria in the RAISE trial to allow for enrollment of patients previously treated with IV anesthesia.


WHO validates Convidecia vaccine for Covid-19
News | May 19, 2022

WHO validates Convidecia vaccine for Covid-19

The vaccine was found to have 64% efficacy against symptomatic disease and 92% against severe Covid-19


Challenges of Thalassemia management in India bring like-minded stakeholders together
Public Health | May 08, 2022

Challenges of Thalassemia management in India bring like-minded stakeholders together

Ahead of International Thalassemia Day on 8th May, medical professionals and representatives of patient bodies participated in a virtual discussion on the current situation of Thalassemia management in India


14.9 million excess deaths associated with the Covid-19 pandemic in 2020 and 2021
News | May 05, 2022

14.9 million excess deaths associated with the Covid-19 pandemic in 2020 and 2021

The report has estimated 4.74 million deaths for India in 2020 and 2021,